Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Vijaypd Ceutical Ltd (VIJAYPD)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: VIJAYPD Trading | Small Cap | Vijaypd Ceutical Share Price
BSE Share Price
Not Listed
Not Listed
Vijaypd Ceutical Ltd (VIJAYPD)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: VIJAYPD Trading | Small Cap | Vijaypd Ceutical Share Price
BSE Share Price
Not Listed
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹154 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
₹2.6
TTM Sales
₹100 Cr.
Book Value per Share
₹26.9
P/E Ratio
30.85
Higher than its 5-year historical median
Industry PE
42.1
Price to Book (P/B)
2.94
Lower than its 5-year historical median
Price to Sales (P/S)
1.54
Higher than its 5-year historical median
EV/EBITDA
19.73
Higher than its 5-year historical median
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
9.53%
Return on Capital Employed (ROCE)
9.12%
Return on Assets (ROA)
5.04%
Operating Profit Margin
4.7%
Net Profit Margin
4.99%
Gross Profit Margin
7.1%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
-1.27%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
56.43%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹33 Cr.
Equity
₹19.5 Cr.
Face Value
₹10
All Time Low / High
₹0.00 / 0.00
Check Before You Invest
Quality
Not GoodValuation
OvervaluedCheck Valuation charts
Price Trend
Strong
Is Vijaypd Ceutical Ltd a good quality company?
Vijaypd Ceutical Ltd is a weak quality company, based on a inconsistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Vijaypd Ceutical Ltd performance compare with that of its Peers?
Revenue growth of Vijaypd Ceutical Ltd vs industry peers?
Vijaypd Ceutical Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of %, indicating stable growth and maintaining its market share.
Promoter shareholding and pledge status of Vijaypd Ceutical Ltd?
Promoters hold 56.43% of the Vijaypd Ceutical Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Vijaypd Ceutical Ltd over the last decade?
Over the last 1 year(s), the stock has delivered a CAGR of 79.55% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Vijaypd Ceutical Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'25 | Mar'26 | TTM | |
|---|---|---|---|
| ROCE % ⓘ | 15.8% | 11.6% | - |
| Value Creation Index ⓘ | 0.1 | -0.2 | - |
Growth Parameters ⓘ |
|||
| Sales ⓘ | 100 | 99 | 99 |
| Sales YoY Gr. | - | -1.3% | - |
| Adj EPS ⓘ | 3.4 | 2.6 | 2.6 |
| YoY Gr. | - | -22.6% | - |
| BVPS (₹) ⓘ | 23.1 | 26.9 | 26.9 |
| Adj Net Profit ⓘ | 4.7 | 5.1 | 5 |
| Cash Flow from Ops. ⓘ | -34.5 | -7.3 | - |
| Debt/CF from Ops. ⓘ | -0.6 | -4.6 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | NA | NA | -1.3% | ||||
| Adj EPS ⓘ | NA | NA | NA | -22.6% | ||||
| BVPSⓘ | NA | NA | NA | 16.4% | ||||
| Share Price | - | - | - | 79.6% | ||||
Key Financial Parameters ⓘ
| Mar'25 | Mar'26 | TTM | |
|---|---|---|---|
| Return on Equity % ⓘ | 14.5 | 11.9 | 9.6 |
| Op. Profit Mgn % ⓘ | 8.4 | 4.8 | NAN |
| Net Profit Mgn % ⓘ | 4.7 | 5.1 | 5.1 |
| Debt to Equity ⓘ | 0.7 | 0.6 | - |
| Working Cap Days ⓘ | 0 | 205 | 0 |
| Cash Conv. Cycle ⓘ | 0 | 123 | 0 |
Valuation of Vijaypd Ceutical - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'26 |
|---|---|
| Sales | 100 |
| Operating Expenses ⓘ + | 96 |
| Operating Profit ⓘ | 5 |
| Operating Profit Margin (%) | 4.7% |
| Other Income ⓘ + | 4 |
| Interest ⓘ | 2 |
| Depreciation ⓘ | 1 |
| Profit Before Tax ⓘ | 6 |
| Tax ⓘ | 1 |
| Profit After Tax | 5 |
| PAT Margin (%) | 5.0% |
| Adjusted EPS (₹) | 2.6 |
| Dividend Payout Ratio (%) | 0% |
| PARTICULARS | Mar'26 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 52 | ||||||||||
| Debt + | 30 | ||||||||||
| Minority Interest | -0 | ||||||||||
| Trade Payables | 8 | ||||||||||
| Others Liabilities ⓘ | 9 | ||||||||||
| Total Liabilities ⓘ | 99 | ||||||||||
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 9 | ||||||||||
| CWIP ⓘ | 2 | ||||||||||
| Investments ⓘ | 0 | ||||||||||
| Inventories | 12 | ||||||||||
| Trade Receivables | 31 | ||||||||||
| Cash Equivalents | 18 | ||||||||||
| Others Assets ⓘ | 28 | ||||||||||
| Total Assets ⓘ | 99 | ||||||||||
| PARTICULARS | Mar'26 |
|---|---|
| Cash Flow From Operating Activity ⓘ + | -9 |
| Cash Flow From Investing Activity ⓘ + | -13 |
| Cash Flow From Financing Activity ⓘ + | 32 |
| Net Cash Flow ⓘ | 10 |
| PARTICULARS | Mar'26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 9.53 | |||||||||
| ROCE (%) | 9.12 | |||||||||
| Asset Turnover Ratio | 1.01 | |||||||||
| PAT to CFO Conversion(x) | -1.8 | |||||||||
| Working Capital Days | ||||||||||
| Receivable Days | 111.40 | |||||||||
| Inventory Days | 45.40 | |||||||||
| Payable Days | 32.70 | |||||||||
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Annual reports
No annual reports available.
Concalls
No concalls available.
Vijaypd Ceutical Ltd FAQs
The current trading price of Vijaypd Ceutical on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Vijaypd Ceutical stood at ₹154.3 Cr
The latest P/E ratio of Vijaypd Ceutical as of 31-Dec-1969 is 30.50.
The latest P/B ratio of Vijaypd Ceutical as of 31-Dec-1969 is 2.94.
The 52-week high of Vijaypd Ceutical is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Vijaypd Ceutical is ₹98.96 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Vijaypd Ceutical Ltd is a below average quality company.
The key valuation ratios of Vijaypd Ceutical Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Vijaypd Ceutical Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing
About Vijaypd Ceutical Ltd
Vijaypd Ceutical was originally formed as a partnership firm under the name and style of ‘M/s. Vijay Pharma’ pursuant to a deed of partnership dated October 05, 1971. Further, M/s. Vijay Pharma was converted into a public limited company ‘Vijaypd Ceutical Limited’ on March 19, 2024. Further, the company has acquired the running business of M/s. P.D. Doshi, a Partnership firm on going concern basis vide Business Transfer Agreement dated April 1, 2024.
The company is engaged in the business of distribution and supply within the pharmaceutical and consumer goods sectors, offering a comprehensive range of services. Its roles include being representatives, dealers, agents, stockists, suppliers, traders, and packers. It offers a wide range of products serving both the pharmaceutical and wellness industries, as well as the fastmoving consumer goods (FMCG) market. Its pharmaceutical and wellness product range includes medicines such as injections, tablets, capsules, ointments, suppositories, ophthalmic preparations, and liquid oral formulations. It also supplies vitamins, hormones, enzymes, wellness tonics, serums, and diagnostic test kits. In the FMCG segment, it provides personal care and toiletry products, including soaps, sanitizers, and baby care items. Additionally, it deals in ayurvedic products, cosmetics, food products, dental products, and crude drugs.
The company is positioning itself to expand its market presence by diversifying into the manufacturing of active pharmaceutical ingredient (APIs) which serves as a raw material for pharmaceutical formulations in preparation of various type of Finished Dosage Formula (FDF) such as tablet, capsules, ointment, syrup etc, and excipients. Further, the company as a pharmaceutical distributor, holds certifications from the Food and Drug Administration (FDA), the Food Safety and Standards Authority of India (FSSAI), and the competent authorities of the Brihanmumbai Municipal Corporation (BMC). These certifications help maintain the integrity of pharmaceutical products throughout storage, handling, and transportation, while also enhancing operational efficiency and quality control.
Business area of the company
The company is engaged in the business of wholesale Distribution of Pharmaceutical products. It offers a wide range of products serving both the pharmaceutical and wellness industries, as well as the FMCG market.
Services provided by the company
- Healthcare products distribution: The company provides distribution and logistics services for healthcare products to retail pharmacies, nursing homes and healthcare clinics.
- Retail distribution: The company’s retail distribution channel involves distributing healthcare products to pharmacies, who then sell these products to end customers.
- Distribution to Clinics, Doctors and Nursing Homes: The company supplies a wide range of healthcare products, including pharmaceutical and nutraceutical products, to nursing homes and clinics through its nationwide distribution network, which consists of its delivery fleet, delivery personnel and local logistics.
- Supply chain and distribution platform: The company serves the customers (including pharmacies, nursing homes and healthcare clinics) through a diverse network of distribution through warehouses.
Awards, accreditations and recognition
- 1999: Received Award from the Pharmaceutical Wholesale’s Association (Mumbai) for Recognition and Sincere Appreciation of distinguished and devoted service rendered in Pharmaceutical Distribution Over 25 Years.
- 2015: Received Award for Securing 3rd Rank in Maharashtra for the Sale Turnover of Cipla FY 2014-15.
- 2016: Received Award from Cipla for Outstanding Contribution and Continued Association, 25 Years of Trust.
- 2017: Received Award towards contribution in making affordable medicines reach out to millions of patients and grow GSK Business.
- 2018: Received Award for GSK National Channel Partner Recognition amongst top contributing pharmaceutical distribution across India for GSK Pharmaceutical Limited.
History and milestones
- 1971: Formed as a Partnership Firm in the name and style of ‘M/s. Vijay Pharma’.
- 2024: Conversion of Partnership Firm into Public Limited Company in the name and style of ‘Vijaypd Ceutical Limited’.
- 2024: The company has acquired the running business of ‘M/s. P.D. Doshi’, a Partnership firm on Going Concern basis.
You have 0 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now